Sign In

​​​​​​​​​​​​​​​​​​​​​ ​​​​​Home Funds and Performance Nippon India ​Pharma Fund.​ ​​​​​​​

Nippon India Pharma Fund

An Open Ended Pharma Sector Scheme

Product Label Close

This product is suitable for investors who are seeking*:

  • Long term capital growth.
  • Investment in equity and equity related securities of pharma and other associated companies.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them

investMore investMore
  • Investment Objective:
    The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of pharma and other associated companies.

Fund PerformanceGrowth Plan - Growth Option

  • Latest NAV (30 Mar 2020)139.6337


NAV as on Jan 31 2020: ` 156.154

Performance of Nippon India Pharma Fund as on 31/01/2020
Particulars1 Year CAGR %3 Year CAGR %5 Year CAGR %Since Inception
Nippon India Pharma Fund 2.96 5.95 3.69 19.18
B: S&P BSE Healthcare TRI1.32-1.29-1.7013.20
AB: S&P BSE Sensex TRI 13.59 15.16 8.29 16.15
Value of `10000 Invested
​Nippon India Pharma Fund 10,296 11,892 11,987 1,56,155
B: S&P BSE Healthcare TRI 10,132 9,618 9,177 69,782
AB: S&P BSE Sensex ​TRI 11,359 15,272 14,895 1,04,396
Inception Date: Jun 5, 2004
​​​B - Benchmark    |   AB - Additional Benchmark |   TRI - Total Return Index
​​​Fund Manager: Sailesh Raj Bhan (Since Jun 2004)​
As TRI data is not available since Since Inception of the scheme, benchmark performance is calculated using composite CAGR of S&P BSE HC PRI values from date 04-Jun-2004 to date 23-Aug-2004 and TRI values since date 23-Aug-2004.
​​

​​PERFORMANCE OF OTHER OPEN ENDED SCHEMES MANAGED BY FUND MANAGER: Sailesh Raj Bhan

Scheme Name/sCAGR %
1 Year Return 3 Years Return5 Years Return
Scheme Benchmark Scheme Benchmark Scheme Benchmark
Nippon India Consumption Fund12.848.646.5511.484.818.67
Nippon India Multi Cap Fund5.7110.8010.9511.665.167.97
Nippon India Large Cap Fund7.1010.5811.9512.477.417.71
​​​

​​Note​:

a.Mr. Sailesh Raj Bhan manages 4 open-ended schemes of Nippon India Mutual Fund.

​b. In case the number of schemes managed by a fund manager is more than six, in the performance data of other schemes, the top 3 and bottom 3 schemes managed by fund manager has been provided herein.

c. Period for which scheme’s performance has been provided is computed basis last day of the month-end preceding the date of advertisement.

d. Different plans shall have a different expense structure. The performance details provided herein are of Growth Plan (Regular Plan).

TRI - Total Returns Index reflects the returns on the index arising from (a) constituent stock price movements and (b) dividend receipts from constituent index stocks, thereby showing a true picture of returns.

The performance of the equity scheme is benchmarked to the Total Return variant of the Index.

Mr. Sailesh Raj Bhan has been managing Nippon India Pharma Fund since Jun 2004, Nippon India Consumption Fund since Sep 2004, Nippon India Multi Cap Fund since Mar 2005, Nippon India Large Cap Fund since Aug 2007

Past performance may or may not be sustained in future and the same may not necessarily provide the basis for comparison with other Investment. Dividends (if any) are assumed to be reinvested at the prevailing NAV. In case of LIQUIDBEES, returns are based on gross dividend per unit declared by the Fund. Bonus (if any) declared has been adjusted. Performance of dividend option would be Net of Dividend distribution tax, if any. Face value of scheme is `10/- per unit. Face Value of Nippon India Low Duration Fund is `1000/- per unit. Face Value of Nippon India Money Market Fund, Nippon India Liquid Fund, Nippon India Ultra Short Duration Fund is `1000/- per unit w.e.f 5th Aug 2012. Face value of Nippon India ETF Junior BeES is `1.25/- per unit. Face value of Nippon India ETF Liquid BeES is `1000/- per unit. Face Value of Nippon India ETF Nifty BeES, Nippon India ETF Bank BeES, Nippon India ETF PSU Bank BeES, Nippon India ETF NV20, Nippon India ETF Hang Seng BeES has changed from `10/- per unit to `1/- per unit w.e.f 20th Dec 2019. Face value of Nippon India ETF Gold BeES has changed from `100/- per unit to `1/- per unit w.e.f 20th Dec 2019. Face value of Nippon India Overnight Fund is `100/- per unit. In case, the start/end date of the concerned period is non-business day (NBD), the NAV of the previous date is considered for computation of returns. Schemes which have not completed one year, performance details for the same are not provided. Performance details of closed ended schemes are not provided since these are not comparable with other schemes.​​​Different plans shall have a different expense structure. The performance details provided herein are of Growth Plan (Regular Plan).

​​​​​ ​​​ ​​​​​
​​
​​



​​​

Read more

Fund Details

  • Inception Date5 Jun 2004
  • Fund ManagerMr. Sailesh Raj Bhan
Current Investment Philosophy
    • The Fund seeks to invest in pharma sector with focus on important segments of the sector viz Domestic Business, International & CRAMS and include deep value as well as high growth pharma businesses.
    • The fund invests across market capitalization within the sector.
    • It may suit investment horizon of around 2-3 years.
Minimum Investment
5000.00

    and in multiples of Re. 1 thereafter

Fund Manager
Load Details

Entry Load*:

Not Applicable

*In terms of SEBI circular no. SEBI/IMD/CIR No.4/ 168230/09 dated June 30, 2009, no entry load will be charged by the Scheme to the investor effective August 1, 2009. Upfront commission shall be paid directly by the investor to the AMFI registered Distributors based on the investors' assessment of various factors including the service rendered by the distributor.

Exit Load**:

10% of the units allotted shall be redeemed without any exit load, on or before completion of 12 months from the date of allotment of units. Any redemption in excess of such limit in the first 12 months from the date of allotment shall be subject to the following exit load.Redemption of units would be done on First in First out Basis (FIFO):

1% if redeemed or switched out on or before completion of 12 months from the date of allotment of units.

Nil, thereafter wef. 17th March 2020.

**If charged, the same shall be credited to the scheme immediately net of Goods & Service tax, if any.

Product label

This product is suitable for investors who are seeking*:

  • Long term capital growth.
  • Investment in equity and equity related securities of pharma and other associated companies.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them



Close

Portfolio

Select

Details as on Feb 29 , 2020

​​

​​Related Downloads & Tools

Tools

  • SIP Calculator​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

    ​​


    ​​​​




    ​​​

How to Invest?

Contact our advisor to complete the process

Other funds in such category

Nippon India Banking Fund An open ended equity scheme investing in Banking sector.-Growth Plan Growth Option

Latest NAV

161.1772 30-Mar-2020

Nippon India Power & Infra Fund An Open Ended Equity Scheme investing in power & infrastructure sectors-Growth Plan - Growth Option

Latest NAV

62.0788 30-Mar-2020

Nippon India Consumption Fund An Open Ended Media & Entertainment Sector Scheme-Growth Plan - Growth Option

Latest NAV

51.6406 30-Mar-2020

Get the app